Actualités

AIS2018

Assises 2018 : Targets for Mabs Innovative Approaches for their Discovery & Validation

Lire la suite

Sans titre

MASTER CLASSES DE L’IMMUNOTHÉRAPIE

Lire la suite

Recruitment, recruit, recruiter.

Development of new immunoconjugates for HER2-positive breast cancers

Lire la suite

Recruitment, recruit, recruiter.

Responsable Business Intelligence

Lire la suite